Profiling the Preclinical Pharmacokinetics and Biodistribution of a Platinum(IV)-Based Oxaliplatin Prodrug OxaliTEX and Their Significance to Antitumor Response

Guangan He(The University of Texas MD Anderson Cancer Center), Zahid H. Siddik(The University of Texas MD Anderson Cancer Center)
Molecular Pharmaceutics
October 29, 2025
Cited by 0


Related Papers